Suppr超能文献

BRD4-脑啡肽降解剂三元复合物的蛋白质错配分析见解显示了强效降解剂与弱效降解剂的区分。

Insights from protein frustration analysis of BRD4-cereblon degrader ternary complexes show separation of strong from weak degraders.

作者信息

Yang Tianyi, Mukhaleva Elizaveta, Wei Wenyuan, Weiss Dahlia, Ma Ning, Shanmugasundaram Veerabahu, Vaidehi Nagarajan

机构信息

Department of Computational and Quantitative Medicine, Beckman Research Institute of the City of Hope 1500, E. Duarte Road Duarte CA 91010 USA

Irell and Manella Graduate School of Biological Sciences, Beckman Research Institute of the City of Hope USA.

出版信息

RSC Med Chem. 2025 Feb 10. doi: 10.1039/d4md00962b.

Abstract

PROteolysis TArgeting Chimeras (PROTACs), also known as ligand-directed degraders (LDDs), are an innovative class of small molecules that leverage the ubiquitin-proteasome system to induce the degradation of target proteins. Structure based design methods are not readily applicable for designing LDDs due to the dynamic nature of the ternary complexes. This study investigates the dynamic properties of five LDD-mediated BRD4-cereblon complexes, focusing on the challenges of evaluating linker efficiency due to the difficulty in identifying suitable computational metrics that correlate well with the cooperativity or degradation propensity of LDDs. We uncovered that protein frustration, a concept originally developed to understand protein folding, calculated for the residues in the protein-protein interface of the LDD-mediated ternary complexes recapitulate the strength of degradation of the LDDs. Our findings indicated that hydrophobic residues in the interface are among the highly frustrated residues pairs, and they are crucial in distinguishing strong degraders from weak ones. By analyzing frustration patterns, we identified key residues and interactions critical to the effectiveness of the ternary complex. These insights provide practical guidelines for designing and prioritizing more efficient degraders, paving the way for the development of next-generation LDDs with improved therapeutic potential.

摘要

蛋白酶靶向嵌合体(PROTACs),也被称为配体导向降解剂(LDDs),是一类创新的小分子,它们利用泛素-蛋白酶体系统诱导靶蛋白降解。由于三元复合物的动态性质,基于结构的设计方法不易应用于设计LDDs。本研究调查了五种LDD介导的BRD4-脑啡肽复合物的动态特性,重点关注评估连接子效率的挑战,因为难以确定与LDDs的协同性或降解倾向良好相关的合适计算指标。我们发现,蛋白质受挫感,这一最初为理解蛋白质折叠而提出的概念,计算LDD介导的三元复合物蛋白质-蛋白质界面中的残基时,能够概括LDDs的降解强度。我们的研究结果表明,界面中的疏水残基属于高度受挫的残基对,它们对于区分强效降解剂和弱效降解剂至关重要。通过分析受挫模式,我们确定了对三元复合物有效性至关重要的关键残基和相互作用。这些见解为设计和优先选择更有效的降解剂提供了实用指南,为开发具有更高治疗潜力的下一代LDDs铺平了道路。

相似文献

本文引用的文献

5
Research progress of PROTACs for neurodegenerative diseases therapy.神经退行性疾病治疗的 PROTACs 研究进展。
Bioorg Chem. 2024 Jun;147:107386. doi: 10.1016/j.bioorg.2024.107386. Epub 2024 Apr 18.
8
AmberTools. AmberTools。
J Chem Inf Model. 2023 Oct 23;63(20):6183-6191. doi: 10.1021/acs.jcim.3c01153. Epub 2023 Oct 8.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验